老年患者的代谢性腹手术:这是值得的吗? 在BARI-10-POL研究中,
Natalia Dowgiałło-Gornowicz1, Paweł Jaworski2, Izabela Karpińska3
1Department of General, Minimally Invasive and Elderly Surgery, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland. natalia.dowgiallo@gmail.com.
Obesity surgery
|October 31, 2025
概括
代谢性减肥手术 (MBS) 在年轻人和老年人中显示出类似的长期减肥和代谢改善. 这种安全有效的程序使不同年龄组受益,在10年后提供可比的结果.
科学领域:
- 老年医学 老年医学
- 外科胃肠道外科手术
- 肥胖问题研究研究
背景情况:
- 肥胖率的上升和预期寿命的增加使得老年人群需要减肥手术.
- 关于代谢性减肥手术 (MBS) 的长期结果存在有限的数据,比较年轻和老年患者.
研究的目的:
- 对30岁以下和60岁以上的患者进行初级代谢性减肥手术 (MBS) 的10年结果进行分析和比较.
主要方法:
- 在2008-2014年期间在波兰进行的腹腔镜MBS的回顾性多中心分析 (BARI-10-POL项目).
- 纳入标准:手术时年龄<30岁或>60岁,随访时间至少10年.
- 两个年龄组之间的减肥,代谢结果和并发症率的比较.
主要成果:
- 分析了49名年轻 (<30岁) 和46名老年 (>60岁) 患者;袖子胃切除术是最常见的.
- 在不同组之间观察到类似的多余体重减轻 (%EWL:59.3% vs 60.2%) 和总体重减轻 (%TWL:21.6% vs 20.5%).
- 老年患者的2型糖尿病和高血压发病率较高,缓解率与年轻患者相比较高;并发症率低且相似 (2.0%对4.3%).
结论:
- 代谢性减肥手术 (MBS) 证明了不同年龄组的长期有效性和安全性.
- 在接受MBS的年轻和老年患者之间,没有发现体重减轻或代谢结果的统计学上显著差异.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
233
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
233
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
164
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
164
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
192
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
192
01:21Drug Dosing: Obese Patients
216
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
216
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182